Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.5959
-0.0141 (-2.31%)
Apr 28, 2026, 4:00 PM EDT - Market closed
MTNB Employees
Matinas BioPharma Holdings had 2 employees as of December 31, 2025. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$5,481,500
Market Cap
3.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | -1 | -33.33% |
| Dec 31, 2024 | 3 | -29 | -90.63% |
| Dec 31, 2023 | 32 | -2 | -5.88% |
| Dec 31, 2022 | 34 | 3 | 9.68% |
| Dec 31, 2021 | 31 | 11 | 55.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tivic Health Systems | 52 |
| Jaguar Health | 47 |
| AIM ImmunoTech | 21 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
MTNB News
- 25 days ago - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 1 year ago - Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - GlobeNewsWire
- 1 year ago - Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors - GlobeNewsWire
- 1 year ago - Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - GlobeNewsWire
- 1 year ago - Matinas BioPharma Receives NYSE Noncompliance Notice - GlobeNewsWire
- 1 year ago - Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - GlobeNewsWire
- 1 year ago - Matinas BioPharma Holdings Earnings Call Transcript: Q2 2024 - Transcripts
- 1 year ago - Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire